High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 14 11 2017
accepted: 29 06 2018
pubmed: 15 8 2018
medline: 18 3 2020
entrez: 15 8 2018
Statut: ppublish

Résumé

The proportion of undiagnosed hepatitis C virus (HCV) infections in high-risk populations, such as human immunodeficiency virus (HIV)-infected men who have sex with men (MSM) is unclear. Identification of potential HCV transmitters is important to reach World Health Organization HCV elimination targets. Between October 2015 and May 2016, we performed a systematic HCV RNA-based screening among HIV-infected MSM participating in the Swiss HIV Cohort Study (SHCS). HCV antibodies were measured from all HCV RNA-positive samples. Of 4257 MSM recorded in the SHCS database, we screened 3722 (87%) by HCV polymerase chain reaction, and 177 (4.8%) harbored a replicating HCV infection. We identified 24 individuals (14%) with incident HCV infection; one-third of them had a negative HCV antibody result at the time of HCV RNA positivity. In a multivariable model, elevated liver enzyme values (odds ratio, 14.52; 95% confidence interval, 9.92-21.26), unprotected sex with occasional partners (2.01; 1.36-2.98), intravenous drug use (7.13; 4.36-11.64), noninjectable drug use (1.94; 1.3-2.88), and previous syphilis diagnosis (2.56; 1.74-3.76) were associated with HCV RNA positivity. A systematic HCV RNA-based screening among HIV-infected MSM revealed a high number of potential transmitters. A substantial subpopulation of MSM had incident infection, one-third of whom had a negative HCV antibody test result at the time of the HCV RNA positivity. These data reveal that one-time RNA testing of a high-risk population for HCV RNA might identify more infected persons than routine testing for HCV antibodies and liver enzymes. NCT02785666.

Sections du résumé

Background
The proportion of undiagnosed hepatitis C virus (HCV) infections in high-risk populations, such as human immunodeficiency virus (HIV)-infected men who have sex with men (MSM) is unclear. Identification of potential HCV transmitters is important to reach World Health Organization HCV elimination targets.
Methods
Between October 2015 and May 2016, we performed a systematic HCV RNA-based screening among HIV-infected MSM participating in the Swiss HIV Cohort Study (SHCS). HCV antibodies were measured from all HCV RNA-positive samples.
Results
Of 4257 MSM recorded in the SHCS database, we screened 3722 (87%) by HCV polymerase chain reaction, and 177 (4.8%) harbored a replicating HCV infection. We identified 24 individuals (14%) with incident HCV infection; one-third of them had a negative HCV antibody result at the time of HCV RNA positivity. In a multivariable model, elevated liver enzyme values (odds ratio, 14.52; 95% confidence interval, 9.92-21.26), unprotected sex with occasional partners (2.01; 1.36-2.98), intravenous drug use (7.13; 4.36-11.64), noninjectable drug use (1.94; 1.3-2.88), and previous syphilis diagnosis (2.56; 1.74-3.76) were associated with HCV RNA positivity.
Conclusions
A systematic HCV RNA-based screening among HIV-infected MSM revealed a high number of potential transmitters. A substantial subpopulation of MSM had incident infection, one-third of whom had a negative HCV antibody test result at the time of the HCV RNA positivity. These data reveal that one-time RNA testing of a high-risk population for HCV RNA might identify more infected persons than routine testing for HCV antibodies and liver enzymes.
Clinical Trials Registration
NCT02785666.

Identifiants

pubmed: 30107494
pii: 5071946
doi: 10.1093/cid/ciy545
doi:

Substances chimiques

RNA, Viral 0

Banques de données

ClinicalTrials.gov
['NCT02785666']

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-568

Investigateurs

A Anagnostopoulos (A)
M Battegay (M)
H C Bucher (HC)
A Calmy (A)
M Cavassini (M)
A Ciuffi (A)
G Dollenmaier (G)
M Egger (M)
L Elzi (L)
J Fellay (J)
H Furrer (H)
C A Fux (CA)
D Haerry (D)
B Hasse (B)
H H Hirsch (HH)
M Hoffmann (M)
I Hösli (I)
M Huber (M)
C Kahlert (C)
L Kaiser (L)
O Keiser (O)
T Klimkait (T)
H Kovari (H)
B Ledergerber (B)
G Martinetti (G)
B Martinez de Tejada (BM)
C Marzolini (C)
K J Metzner (KJ)
N Müller (N)
D Nicca (D)
P Paioni (P)
G Pantaleo (G)
M Perreau (M)
C Rudin (C)
A U Scherrer (AU)
R Speck (R)
P Tarr (P)
A Trkola (A)
P Vernazza (P)
G Wandeler (G)
R Weber (R)
S Yerly (S)

Commentaires et corrections

Type : CommentIn

Auteurs

Dominique L Braun (DL)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.
Institute of Medical Virology, University of Zurich.

Benjamin Hampel (B)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.
Institute of Medical Virology, University of Zurich.

Eileen Martin (E)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.

Roger Kouyos (R)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.
Institute of Medical Virology, University of Zurich.

Katharina Kusejko (K)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.
Institute of Medical Virology, University of Zurich.

Christina Grube (C)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.

Markus Flepp (M)

Center of Infectious Diseases Zurich.

Marcel Stöckle (M)

Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel.

Anna Conen (A)

Division of Infectious Diseases and Hospital Hygiene, Cantonal Hospital Aarau.

Charles Béguelin (C)

Department of Infectious Diseases, Bern University Hospital, University of Bern.

Patrick Schmid (P)

Division of Infectious Diseases, Cantonal Hospital St Gallen.

Julie Delaloye (J)

Intensive Care Unit, Department of Intensive Care Medicine, University of Lausanne and University Hospital Center.

Mathieu Rougemont (M)

Division of Infectious Diseases, University Hospital Geneva.

Enos Bernasconi (E)

Division of Infectious Diseases, Regional Hospital Lugano.

Andri Rauch (A)

Department of Infectious Diseases, Bern University Hospital, University of Bern.

Huldrych F Günthard (HF)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.

Jürg Böni (J)

Institute of Medical Virology, University of Zurich.

Jan S Fehr (JS)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.
Department of Public Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH